objective:observe the therapeutic effect and lab index changes of metaphase late liver cancer treated by matrine injection together with tace operation.
目的:观察苦参堿注射液配合tace术治疗晚期肝癌的疗效及实验室指标的变化。
methods 12 patients with liver cancer used tace then observed clinical efficacy .
对12例肝癌采用经肝动脉灌注化疗栓塞治疗,观察临床疗效。
all the complications were cured. conclusion: serious ischemic complications of tace occur in about 3.5% of patients and it can be successfully treated with interventional radiologic procedure.
结论:tace术后严重缺血性并发癥的发生率约为3.5 % ,可用介入放射学方法进行有效的治疗。
conclusion:combination tace and pei in the treatments of hcc may prevent distant metastasis of hcc or hcc recurrence.
conclusion: repeated tace is a safe and effective method for treatment of hepatic metastases from gastrointestinal tumors, including cases with hypovascular lesions.
结论:动脉化疗栓塞法治疗胃肠道肿瘤肝转移有确切疗效,对于乏血供转移灶亦有良好效果。
now you can schedule a more intensive tace regimen, keeping the response in place without toxicity.
现在我们可以安排一个更合适的化疗方案,既保持疗效又不产生毒性。
methods: 33 patients with primary hepatocellular carcinoma received tace therapy and 48 healthy subjects served as controls in this study.
方法:33例接受tace治疗的原发性肝癌患者和48例正常对照者纳入研究。
conclusion tace is one of the safe and effective micro - operative therapy for advanced hepatic carcinoma, and cancer embolus in main branch of portal vein may not be the contraindication of tace.